Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Other Accumulated Expenses (2016 - 2025)

Collegium Pharmaceutical has reported Other Accumulated Expenses over the past 10 years, most recently at $6.4 million for Q3 2025.

  • Quarterly results put Other Accumulated Expenses at $6.4 million for Q3 2025, up 31.42% from a year ago — trailing twelve months through Sep 2025 was $6.4 million (up 31.42% YoY), and the annual figure for FY2024 was $4.8 million, up 32.17%.
  • Other Accumulated Expenses for Q3 2025 was $6.4 million at Collegium Pharmaceutical, up from $4.3 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for COLL hit a ceiling of $6.4 million in Q3 2025 and a floor of $578000.0 in Q1 2021.
  • Median Other Accumulated Expenses over the past 5 years was $3.4 million (2022), compared with a mean of $3.4 million.
  • Biggest five-year swings in Other Accumulated Expenses: plummeted 63.74% in 2021 and later soared 816.61% in 2022.
  • Collegium Pharmaceutical's Other Accumulated Expenses stood at $2.8 million in 2021, then grew by 21.28% to $3.4 million in 2022, then rose by 4.41% to $3.6 million in 2023, then surged by 32.17% to $4.8 million in 2024, then soared by 33.98% to $6.4 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $6.4 million (Q3 2025), $4.3 million (Q2 2025), and $4.8 million (Q1 2025) per Business Quant data.